NO20043366L - Kortikotropinfrigjorende faktor-2 reseptoragonister - Google Patents

Kortikotropinfrigjorende faktor-2 reseptoragonister

Info

Publication number: NO20043366L
Authority: NO; Norway
Prior art keywords: corticotropin; receptor agonists; releasing factor; releasing; factor
Prior art date: 2002-01-16

Application number

NO20043366A

Other languages

English (en)

Norwegian (no)

Inventor

Adam Wieslaw Mazur

Robert Joseph Isfort

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-16

Filing date

2004-08-13

Publication date

2004-10-06

2004-08-13 Application filed by Procter & Gamble filed Critical Procter & Gamble

2004-10-06 Publication of NO20043366L publication Critical patent/NO20043366L/no

Links

101000957708 Catostomus commersonii Corticoliberin-2 Proteins 0.000 title 1
239000000018 receptor agonist Substances 0.000 title 1
229940044601 receptor agonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20043366A 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister NO20043366L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US34911702P	2002-01-16	2002-01-16
US37633702P	2002-04-29	2002-04-29
US38889502P	2002-06-14	2002-06-14
US41198802P	2002-09-19	2002-09-19
PCT/US2003/001461 WO2003062269A2 (en)	2002-01-16	2003-01-16	Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number	Publication Date
NO20043366L true NO20043366L (no)	2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20043366A NO20043366L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043371A NO20043371L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043396A NO20043396L (no)	2002-01-16	2004-08-16	Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO20043371A NO20043371L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043396A NO20043396L (no)	2002-01-16	2004-08-16	Kortikotropinfrigjorende faktorreseptor 2-agonister

Country Status (29)

Country	Link
US (7)	US6936585B2 (pl)
EP (4)	EP1724283B1 (pl)
JP (3)	JP4508648B2 (pl)
KR (3)	KR100758858B1 (pl)
CN (3)	CN1617887A (pl)
AR (3)	AR038142A1 (pl)
AT (4)	ATE334147T1 (pl)
AU (2)	AU2003237419B2 (pl)
BR (3)	BR0306838A (pl)
CA (3)	CA2470656C (pl)
CY (1)	CY1106133T1 (pl)
DE (4)	DE60307044T2 (pl)
DK (2)	DK1465923T3 (pl)
ES (4)	ES2287484T3 (pl)
IL (5)	IL162529A0 (pl)
MA (3)	MA27590A1 (pl)
MX (3)	MXPA04006884A (pl)
MY (1)	MY140306A (pl)
NO (3)	NO20043366L (pl)
NZ (3)	NZ533598A (pl)
PE (3)	PE20030747A1 (pl)
PL (3)	PL373529A1 (pl)
PT (2)	PT1465923E (pl)
RU (1)	RU2294333C2 (pl)
SA (3)	SA03230565B1 (pl)
SI (1)	SI1465921T1 (pl)
TW (3)	TW200302278A (pl)
WO (3)	WO2003062269A2 (pl)
ZA (1)	ZA200404995B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002024732A2 (en) *	2000-09-22	2002-03-28	Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften	Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US6936585B2 (en) *	2002-01-16	2005-08-30	The Procter & Gamble Company	Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) *	2004-04-24	2005-11-03	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
WO2006110413A2 (en) *	2005-03-30	2006-10-19	Novartis Vaccines And Diagnostics Inc.	Haemophilus influenzae type b
WO2007090087A2 (en) *	2006-01-27	2007-08-09	Research Development Foundation	Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
WO2009040027A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of the peptide stresscopin as a therapeutic agent
WO2009046874A1 (en) *	2007-09-11	2009-04-16	Mondobiotech Laboratories Ag	Therapeutic combination of trh-potentiating peptide and stresscopin
WO2009040047A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Therapeutic uses of ghrelin and combinations with stresscopin
EP2362881B1 (en) *	2008-11-04	2019-03-13	Janssen Pharmaceutica NV	Crhr2 peptide agonists and uses thereof
EP2206726A1 (en) *	2009-01-08	2010-07-14	Universite Joseph Fourier	Non-invasive tools for detecting vulnerable atherosclerotic plaques
CN102711801A (zh) *	2009-11-04	2012-10-03	詹森药业有限公司	用顶压素样肽治疗心力衰竭的方法
US9314506B2 (en)	2011-10-24	2016-04-19	Research Development Foundation	Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
BR112014020127A2 (pt) *	2012-02-14	2020-06-30	The Regents Of The University Of Calefornia	métodos para tratamento, melhoramento ou proteção (prevenção) de um indivíduo ou um paciente, e de uma disfunção, uma doença, uma infecção ou uma condição, e, método para suprimir o ganho de peso, ou suprimir o apepite, ou estimular ou iniciar a perda de peso
JOP20170153A1 (ar) *	2016-07-15	2019-01-30	Lilly Co Eli	نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
AU2017345785A1 (en) *	2016-10-20	2019-05-16	Cortene Inc.	Methods of treating diseases resulting from a maladapted stress response
CN110755434B (zh) *	2018-07-27	2022-03-15	中国医学科学院药物研究所	化合物palosuran防治骨骼肌萎缩等疾病的用途
WO2025184558A1 (en) *	2024-02-28	2025-09-04	Caradon Therapeutics, Inc.	Modified urocortin 3
TW202544027A (zh) *	2024-04-19	2025-11-16	美商紐羅克里生物科學有限公司	促皮質素釋放因子受體２（ｃｒｆｒ２）促效劑
WO2025230248A1 (ko) *	2024-04-30	2025-11-06	한미약품 주식회사	Crf2 수용체 작용제와 그 아실화 결합체의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5235036A (en) *	1991-05-31	1993-08-10	The Salk Institute For Biological Studies	Crf analogs
US5786203A (en) *	1994-06-14	1998-07-28	Neurocrine Biosciences, Inc.	Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
EP0860501A3 (en)	1994-06-14	1999-05-19	Neurocrine Biosciences, Inc.	Corticotropin-releasing factor2 receptors
US5663292A (en) *	1994-12-12	1997-09-02	The Salk Institute For Biological Studies	Cyclic CRF analogs
US5824771A (en) *	1994-12-12	1998-10-20	The Salk Institute For Biological Studies	Cyclic CRF agonists
US5660824A (en)	1995-05-24	1997-08-26	Grabstein; Kenneth H.	Muscle trophic factor
CA2223792A1 (en)	1995-06-13	1997-01-03	The Salk Institute For Biological Studies	Urocortin peptides
US5869450A (en)	1996-03-06	1999-02-09	The Regents Of The University Of California	Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
RU2278871C2 (ru)	2000-08-04	2006-06-27	Рисерч Дивелопмент Фаундейшн	Белки урокортина и их применения
WO2002024732A2 (en) *	2000-09-22	2002-03-28	Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften	Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US20020082409A1 (en)	2000-10-26	2002-06-27	Hsu Sheau Yu	Stresscopins and their uses
US6670140B2 (en) *	2001-03-06	2003-12-30	The Procter & Gamble Company	Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6936585B2 (en) *	2002-01-16	2005-08-30	The Procter & Gamble Company	Corticotropin releasing factor 2 receptor agonists

2002
- 2002-12-11 US US10/317,252 patent/US6936585B2/en not_active Expired - Lifetime
- 2002-12-11 US US10/317,251 patent/US7192924B2/en not_active Expired - Fee Related
- 2002-12-11 US US10/315,964 patent/US7192923B2/en not_active Expired - Fee Related
2003
- 2003-01-10 TW TW092100535A patent/TW200302278A/zh unknown
- 2003-01-10 TW TW092100533A patent/TWI300442B/zh not_active IP Right Cessation
- 2003-01-10 TW TW092100532A patent/TW200302276A/zh unknown
- 2003-01-14 PE PE2003000039A patent/PE20030747A1/es not_active Application Discontinuation
- 2003-01-14 PE PE2003000041A patent/PE20030849A1/es not_active Application Discontinuation
- 2003-01-14 PE PE2003000040A patent/PE20030974A1/es not_active Application Discontinuation
- 2003-01-15 AR ARP030100099A patent/AR038142A1/es unknown
- 2003-01-15 MY MYPI20030136A patent/MY140306A/en unknown
- 2003-01-15 AR ARP030100101A patent/AR038144A1/es unknown
- 2003-01-15 AR ARP030100100A patent/AR038143A1/es unknown
- 2003-01-16 AT AT03703867T patent/ATE334147T1/de not_active IP Right Cessation
- 2003-01-16 MX MXPA04006884A patent/MXPA04006884A/es active IP Right Grant
- 2003-01-16 CA CA2470656A patent/CA2470656C/en not_active Expired - Fee Related
- 2003-01-16 KR KR1020047011057A patent/KR100758858B1/ko not_active Expired - Fee Related
- 2003-01-16 RU RU2004124847/13A patent/RU2294333C2/ru active
- 2003-01-16 AT AT03731965T patent/ATE362488T1/de not_active IP Right Cessation
- 2003-01-16 WO PCT/US2003/001461 patent/WO2003062269A2/en not_active Ceased
- 2003-01-16 IL IL15252903A patent/IL162529A0/xx unknown
- 2003-01-16 EP EP06117810A patent/EP1724283B1/en not_active Expired - Lifetime
- 2003-01-16 NZ NZ533598A patent/NZ533598A/en unknown
- 2003-01-16 CN CNA038023709A patent/CN1617887A/zh active Pending
- 2003-01-16 KR KR1020047011051A patent/KR100735586B1/ko not_active Expired - Fee Related
- 2003-01-16 PL PL03373529A patent/PL373529A1/pl not_active Application Discontinuation
- 2003-01-16 IL IL16253003A patent/IL162530A0/xx unknown
- 2003-01-16 CN CNB038023520A patent/CN100475844C/zh not_active Expired - Fee Related
- 2003-01-16 KR KR1020047011052A patent/KR100758857B1/ko not_active Expired - Fee Related
- 2003-01-16 SI SI200330360T patent/SI1465921T1/sl unknown
- 2003-01-16 CA CA2470743A patent/CA2470743C/en not_active Expired - Fee Related
- 2003-01-16 IL IL16243103A patent/IL162431A0/xx unknown
- 2003-01-16 BR BR0306838-2A patent/BR0306838A/pt not_active Application Discontinuation
- 2003-01-16 CN CNB038023644A patent/CN100391972C/zh not_active Expired - Fee Related
- 2003-01-16 JP JP2003562145A patent/JP4508648B2/ja not_active Expired - Fee Related
- 2003-01-16 DE DE60307044T patent/DE60307044T2/de not_active Expired - Lifetime
- 2003-01-16 WO PCT/US2003/001454 patent/WO2003062277A1/en not_active Ceased
- 2003-01-16 ES ES03731965T patent/ES2287484T3/es not_active Expired - Lifetime
- 2003-01-16 ES ES03731963T patent/ES2299701T3/es not_active Expired - Lifetime
- 2003-01-16 WO PCT/US2003/001451 patent/WO2003062268A2/en not_active Ceased
- 2003-01-16 ES ES06117810T patent/ES2309909T3/es not_active Expired - Lifetime
- 2003-01-16 DE DE60321730T patent/DE60321730D1/de not_active Expired - Lifetime
- 2003-01-16 PL PL03373139A patent/PL373139A1/pl not_active Application Discontinuation
- 2003-01-16 ES ES03703867T patent/ES2269976T3/es not_active Expired - Lifetime
- 2003-01-16 CA CA2470731A patent/CA2470731C/en not_active Expired - Fee Related
- 2003-01-16 EP EP03731965A patent/EP1465923B1/en not_active Expired - Lifetime
- 2003-01-16 AT AT06117810T patent/ATE398632T1/de not_active IP Right Cessation
- 2003-01-16 BR BR0306878-1A patent/BR0306878A/pt not_active IP Right Cessation
- 2003-01-16 AU AU2003237419A patent/AU2003237419B2/en not_active Ceased
- 2003-01-16 AU AU2003205197A patent/AU2003205197B2/en not_active Ceased
- 2003-01-16 DK DK03731965T patent/DK1465923T3/da active
- 2003-01-16 EP EP03703867A patent/EP1465921B1/en not_active Expired - Lifetime
- 2003-01-16 PT PT03731965T patent/PT1465923E/pt unknown
- 2003-01-16 PL PL03371364A patent/PL371364A1/pl unknown
- 2003-01-16 BR BR0306826-9A patent/BR0306826A/pt not_active IP Right Cessation
- 2003-01-16 MX MXPA04006885A patent/MXPA04006885A/es active IP Right Grant
- 2003-01-16 EP EP03731963A patent/EP1465922B1/en not_active Expired - Lifetime
- 2003-01-16 DK DK03703867T patent/DK1465921T3/da active
- 2003-01-16 DE DE60318547T patent/DE60318547T2/de not_active Expired - Lifetime
- 2003-01-16 AT AT03731963T patent/ATE383372T1/de not_active IP Right Cessation
- 2003-01-16 JP JP2003562154A patent/JP4489434B2/ja not_active Expired - Fee Related
- 2003-01-16 JP JP2003562146A patent/JP4508649B2/ja not_active Expired - Fee Related
- 2003-01-16 MX MXPA04006883A patent/MXPA04006883A/es active IP Right Grant
- 2003-01-16 NZ NZ533599A patent/NZ533599A/en unknown
- 2003-01-16 PT PT03703867T patent/PT1465921E/pt unknown
- 2003-01-16 DE DE60313845T patent/DE60313845T2/de not_active Expired - Lifetime
- 2003-01-16 NZ NZ533600A patent/NZ533600A/en unknown
- 2003-03-01 SA SA3230565A patent/SA03230565B1/ar unknown
- 2003-03-01 SA SA03230564D patent/SA03230564A/ar unknown
- 2003-03-01 SA SA3230564A patent/SA03230564B1/ar unknown
2004
- 2004-06-24 ZA ZA2004/04995A patent/ZA200404995B/en unknown
- 2004-07-13 MA MA27778A patent/MA27590A1/fr unknown
- 2004-07-13 MA MA27780A patent/MA27592A1/fr unknown
- 2004-07-13 MA MA27779A patent/MA27591A1/fr unknown
- 2004-08-13 NO NO20043366A patent/NO20043366L/no not_active Application Discontinuation
- 2004-08-13 NO NO20043371A patent/NO20043371L/no not_active Application Discontinuation
- 2004-08-16 NO NO20043396A patent/NO20043396L/no not_active Application Discontinuation
2005
- 2005-05-04 US US11/121,612 patent/US7462597B2/en not_active Expired - Fee Related
2006
- 2006-07-28 CY CY20061101051T patent/CY1106133T1/el unknown
2007
- 2007-02-02 US US11/701,576 patent/US7608701B2/en not_active Expired - Fee Related
- 2007-02-02 US US11/701,912 patent/US7632933B2/en not_active Expired - Fee Related
2009
- 2009-01-07 IL IL196384A patent/IL196384A0/en unknown
- 2009-03-24 IL IL197774A patent/IL197774A0/en unknown
- 2009-10-26 US US12/605,718 patent/US7897731B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1724283B1 (en)	2008-06-18
KR20040082389A (ko)	2004-09-24
EP1465921A2 (en)	2004-10-13
DE60321730D1 (de)	2008-07-31
PL373139A1 (pl)	2005-08-22
US7192923B2 (en)	2007-03-20
DE60318547T2 (de)	2008-12-24
JP2005525101A (ja)	2005-08-25
US20060025339A1 (en)	2006-02-02
US20090124793A1 (en)	2009-05-14
DK1465923T3 (da)	2007-07-02
ZA200404995B (en)	2005-06-29
KR20040082390A (ko)	2004-09-24
US7608701B2 (en)	2009-10-27
IL162431A0 (en)	2005-11-20
US20030148958A1 (en)	2003-08-07
RU2004124847A (ru)	2005-04-20
KR100735586B1 (ko)	2007-07-04
CA2470743C (en)	2011-12-13
CN1617887A (zh)	2005-05-18
JP4508648B2 (ja)	2010-07-21
DE60313845D1 (de)	2007-06-28
CY1106133T1 (el)	2011-06-08
US20030148956A1 (en)	2003-08-07
AR038144A1 (es)	2004-12-29
ATE398632T1 (de)	2008-07-15
CN1617885A (zh)	2005-05-18
IL162529A0 (en)	2005-11-20
NZ533600A (en)	2007-02-23
MA27590A1 (fr)	2005-11-01
DE60307044T2 (de)	2007-02-15
CA2470731C (en)	2011-06-21
SA03230565B1 (ar)	2006-10-31
PE20030849A1 (es)	2003-12-01
BR0306826A (pt)	2005-09-06
NO20043371L (no)	2004-10-06
US20080004435A1 (en)	2008-01-03
DE60313845T2 (de)	2008-01-31
MXPA04006884A (es)	2004-12-06
CN100475844C (zh)	2009-04-08
ES2299701T3 (es)	2008-06-01
MXPA04006885A (es)	2004-12-06
EP1465922A2 (en)	2004-10-13
CA2470656C (en)	2011-06-28
HK1078095A1 (zh)	2006-03-03
EP1724283A3 (en)	2007-04-11
BR0306838A (pt)	2005-04-05
SA03230565A (ar)	2005-12-03
ES2269976T3 (es)	2007-04-01
PT1465923E (pt)	2007-08-06
ATE383372T1 (de)	2008-01-15
PT1465921E (pt)	2006-12-29
SA03230564B1 (ar)	2006-10-31
PL371364A1 (pl)	2005-06-13
CA2470731A1 (en)	2003-07-31
EP1465921B1 (en)	2006-07-26
AR038142A1 (es)	2004-12-29
PE20030747A1 (es)	2003-10-23
JP2005521387A (ja)	2005-07-21
TW200302277A (en)	2003-08-01
EP1465923B1 (en)	2007-05-16
ATE334147T1 (de)	2006-08-15
US7192924B2 (en)	2007-03-20
US20030148957A1 (en)	2003-08-07
ES2287484T3 (es)	2007-12-16
EP1465923A1 (en)	2004-10-13
CA2470743A1 (en)	2003-07-31
MY140306A (en)	2009-12-31
DE60318547D1 (de)	2008-02-21
US6936585B2 (en)	2005-08-30
ES2309909T3 (es)	2008-12-16
WO2003062268A2 (en)	2003-07-31
RU2294333C2 (ru)	2007-02-27
TW200302276A (en)	2003-08-01
KR20040082392A (ko)	2004-09-24
WO2003062269A2 (en)	2003-07-31
KR100758857B1 (ko)	2007-09-14
JP2005522191A (ja)	2005-07-28
IL196384A0 (en)	2011-07-31
KR100758858B1 (ko)	2007-09-14
US20100197579A1 (en)	2010-08-05
SI1465921T1 (sl)	2006-10-31
JP4489434B2 (ja)	2010-06-23
AU2003237419B2 (en)	2006-04-13
ATE362488T1 (de)	2007-06-15
CN100391972C (zh)	2008-06-04
EP1465922B1 (en)	2008-01-09
WO2003062268A3 (en)	2003-11-27
DE60307044D1 (de)	2006-09-07
PL373529A1 (pl)	2005-09-05
PE20030974A1 (es)	2003-12-26
NO20043396L (no)	2004-10-06
TW200302278A (en)	2003-08-01
JP4508649B2 (ja)	2010-07-21
SA03230564A (ar)	2005-12-03
IL162530A0 (en)	2005-11-20
DK1465921T3 (da)	2006-11-27
MA27592A1 (fr)	2005-11-01
US7897731B2 (en)	2011-03-01
CA2470656A1 (en)	2003-07-31
MA27591A1 (fr)	2005-11-01
WO2003062269A3 (en)	2003-11-06
IL197774A0 (en)	2009-12-24
MXPA04006883A (es)	2004-12-06
TWI300442B (en)	2008-09-01
EP1724283A2 (en)	2006-11-22
NZ533598A (en)	2007-03-30
AR038143A1 (es)	2004-12-29
US7462597B2 (en)	2008-12-09
CN1617886A (zh)	2005-05-18
WO2003062277A1 (en)	2003-07-31
AU2003205197B2 (en)	2006-03-02
US7632933B2 (en)	2009-12-15
BR0306878A (pt)	2004-10-26
NZ533599A (en)	2007-03-30

Legal Events

Date	Code	Title	Description
2010-08-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
NO20043366L (no)	2004-10-06	Kortikotropinfrigjorende faktor-2 reseptoragonister
FI20030006A7 (fi)	2003-07-08	Yhteiskäyttöverkko
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
ATE388937T1 (de)	2008-03-15	Agonisten des cannabinoidrezeptors
DE60330392D1 (de)	2010-01-14	Cb 1 rezeptor inversagonisten
NO20034483D0 (no)	2003-10-07	Tilkoblingsanordning for områdenett
DE60328925D1 (de)	2009-10-01	Jittergenerator
DE60329184D1 (de)	2009-10-22	Es netzwerk
ATE557036T1 (de)	2012-05-15	Ox40 rezeptor bindende agenzien
NO20052512D0 (no)	2005-05-25	Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
DE60336314D1 (de)	2011-04-21	Substituierte indole
DE50307455D1 (de)	2007-07-26	Einstellsystem
DE60303333D1 (de)	2006-04-13	Schwenkbare Kameravorrichtung
ATE317844T1 (de)	2006-03-15	Adenosine a2a receptor antagonisten
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
DE50302630D1 (de)	2006-05-04	Verstellantrieb
ATE432282T1 (de)	2009-06-15	2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
NO20044373L (no)	2004-10-14	Azetidinderivater som CCR-3-reseptorantagonister
IS7582A (is)	2004-12-03	Hraðlosandi lyfjablanda
DE60324018D1 (de)	2008-11-20	Agonisten
DE60300310D1 (de)	2005-03-17	Keilvorrichtung
NO20043799L (no)	2004-09-10	2-oksasolaminer og deres anvendelse som 5-HT2B reseptor antagonister
NO20023047A (no)	2003-09-01	Kompenseringsanordning
DE60325211D1 (de)	2009-01-22	Lichtstrahlformvorrichtung